Alvameline
Introduction '''Alvameline''' ('''Lu 25-109''') is a M1 receptor agonist and M2/M3 receptor antagonist that was under investigation for the treatment of Alzheimer's disease, but produced poor results in clinical trials and was subsequently discontinued.
See also * Milameline* Sabcomeline* Tazomeline* Xanomeline
References